SHW

From a fundamental perspective, Sherwin-Williams boasts impressive growth metrics, with a year-over-year revenue growth rate of 206.0% and a quarter-over-quarter revenue growth of 6.8%. The company’s earnings per share (EPS) stands at $10.43, reflecting a 7.5% increase QoQ. However, the stock’s valuation appears elevated with a P/E ratio of 30.8 and a forward P/E of 27.3, especially considering the industry average. The gross margin is exceptionally high at 4893.5%, while the operating margin is also strong at 1614.0%. Analysts collectively rate the stock as a buy, with a target price of $372.95, indicating a potential upside despite the current valuation concerns.

Looking ahead, Sherwin-Williams is scheduled to report its next earnings on July 20, 2026. This upcoming earnings release is critical as it will provide insights into whether the company can maintain its growth trajectory amidst the high valuation and potential margin compression. Investors should monitor any changes in revenue growth and margins closely, particularly in light of recent news suggesting the stock could be undervalued by 14%. The market's reaction to the earnings announcement could set the tone for the stock’s performance in the coming weeks.